EEG@HOME (Phase 3b of the Project, Interviews)

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02428348

Enrollment

Registered

2015-04-28

Start date

2015-01-31

Completion date

2015-10-31

Last updated

2017-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The goal of this project is the development of an EEG-cap (min. 21 electrodes) with user-friendly active dry electrodes that meets the expectations of the users regarding comfort and esthetics, without losing sight of the functional and technical demands for recording high quality EEG signals. The purpose is to use the EEG-cap to investigate clinical neurological disorders (e.g. epilepsy). The EEG-cap could also be used at home so that hospital admission in the EMU can be avoided for some patients and an increasing number of patients can be examined. Phase 3 of this Project will be divided into Phase 3a and Phase 3b. In Phase 3b of the project epilepsy patients and their family will be interviewed about different EEG-cap models in development. This interview is anticipated to take approximately 1 hour. Minimum 4 - maximum 20 epilepsy patients and their family will be interviewed. The results of the interviews will be analysed by the design company pilipili nv.

Interventions

OTHERInterview about prototype EEG-cap

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

6 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Epilepsy patient

Exclusion criteria

* No experience with EEG

Design outcomes

Primary

Measure	Time frame
User opinion (questionnaire)	1 hour

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026